Merck & Co. Inc. (MRK): Price and Financial Metrics

MRK POWR Grades

• MRK scores best on the Value dimension, with a Value rank ahead of 85.93% of US stocks.
• MRK's strongest trending metric is Quality; it's been moving down over the last 52 weeks.
• MRK ranks lowest in Momentum; there it ranks in the 18th percentile.

MRK Stock Summary

• MRK has a higher market value than 98.91% of US stocks; more precisely, its current market capitalization is $205,471,684,074.
• MRK's went public 35.83 years ago, making it older than 92.68% of listed US stocks we're tracking.
• In terms of volatility of its share price, MRK is more volatile than just 0.57% of stocks we're observing.
• Stocks that are quantitatively similar to MRK, based on their financial statements, market capitalization, and price volatility, are LLY, INTC, TXN, PFE, and NVS.
• MRK's SEC filings can be seen here. And to visit Merck & Co Inc's official web site, go to www.merck.com.

MRK Valuation Summary

• MRK's price/earnings ratio is 34.7; this is 4.93% lower than that of the median Healthcare stock.
• Over the past 243 months, MRK's price/sales ratio has gone up 0.7.
• Over the past 243 months, MRK's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for MRK.

MRK Growth Metrics

• The year over year net cashflow from operations growth rate now stands at -11.51%.
• Its 5 year price growth rate is now at 52.29%.
• The 5 year net cashflow from operations growth rate now stands at 3.14%.

Over the past 30 months, MRK's revenue has gone up $6,254,000,000.

The table below shows MRK's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	48,548	10,460	5,571
2021-03-31	48,018	11,337	7,028
2020-12-31	47,994	10,253	7,067
2020-09-30	47,348	11,041	11,518
2020-06-30	47,194	13,094	10,478
2020-03-31	48,082	12,811	10,146

MRK's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• MRK has a Quality Grade of B, ranking ahead of 77.69% of graded US stocks.
• MRK's asset turnover comes in at 0.535 -- ranking 77th of 681 Pharmaceutical Products stocks.
• XTNT, ACOR, and NBIX are the stocks whose asset turnover ratios are most correlated with MRK.

The table below shows MRK's key quality metrics over time.